More than six years after the start of the Covid pandemic, millions of people continue to experience long Covid, a persistent condition that remains challenging to treat effectively. A clinical trial conducted by University College London and University College London Hospitals has identified a potential therapeutic approach using over-the-counter antihistamines combined with a prescription anti-inflammatory medication called colchicine. The research demonstrated that this drug combination provided a modest reduction in fatigue symptoms for long Covid patients, though researchers emphasized that the treatment does not constitute a cure for the condition.
Professor Danny Altmann, an immunologist at Imperial College London, discussed the new research findings and highlighted the complexities involved in understanding long Covid. He also noted several upcoming studies that may contribute to better comprehension of the condition and potentially lead to more effective treatment strategies in the future.
In related healthcare developments, the radio program also covered accessibility improvements for individuals with stomas. According to Colostomy UK, approximately one in 335 people in the United Kingdom are living with a stoma, yet more than 60 per cent of this population report that inadequate toilet facilities negatively impact their daily lives. Following a campaign that originated in Bristol, the retail chain B&Q has implemented modifications to the disabled toilets across its stores to make them stoma-friendly, improving accessibility for customers with this condition.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI